The human DNA tumor virus adenovirus replicates productively in human cells and transforms primary rodent epithelial cells. Integral to these activities is the deregulation of cell cycle control and the inhibition of programmed cell death (apoptosis) by the viral oncogenes E1A and E1B. E1A induces S-phase, which is required for replication of viral DNA and stimulation of cell proliferation in transformation. E1A also induces apoptosis that it requires E1B to inhibit to sustain productive infection and permit oncogenic transformation. E1A deregulates the cell cycle by binding to and inhibiting negative regulators of cell growth, one of which is the retinoblastoma tumor suppressor gene product (Rb). E1B encodes two proteins that block apoptosis by binding to and inhibiting pro-apoptotic proteins: 55K binds and inhibits the p53 tumor suppressor protein; 19K binds and inhibits Bax and other related pro-apoptotic components of the apoptotic machinery. I propose to extend these studies in two specific areas that center around the mechanism of modulation of death receptor signaling by E1A and E1B during infection of human cells, and the mechanism of inhibition of p53-dependent apoptosis downstream of mitochondria by the E1B 19K protein in rodent cells. Finally, mice mutant for known components on the apoptotic machinery will be utilized to establish the requirement and ordering of these gene products in cell death signaling pathways in viral infection and transformation. By executing these aims we hope to illuminate novel mechanisms of cell death regulation and how they relate to virus replication and the development of cancer. Knowledge gained from this approach will be useful in the development of new anti-viral and anti-cancer regimens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
3R37CA053370-13S1
Application #
6788638
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Rosenfeld, Bobby
Project Start
1991-01-01
Project End
2006-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
13
Fiscal Year
2003
Total Cost
$102,534
Indirect Cost
Name
Rutgers University
Department
Type
Schools of Medicine
DUNS #
001912864
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Kimmelman, Alec C; White, Eileen (2017) Autophagy and Tumor Metabolism. Cell Metab 25:1037-1043
Strohecker, A M; Joshi, S; Possemato, R et al. (2015) Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel autophagy regulator by high content shRNA screening. Oncogene 34:5662-76
White, Eileen (2015) The role for autophagy in cancer. J Clin Invest 125:42-6
Strohecker, Anne M; White, Eileen (2014) Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism. Autophagy 10:384-5
Mathew, Robin; Khor, Sinan; Hackett, Sean R et al. (2014) Functional role of autophagy-mediated proteome remodeling in cell survival signaling and innate immunity. Mol Cell 55:916-930
Karsli-Uzunbas, Gizem; Guo, Jessie Yanxiang; Price, Sandy et al. (2014) Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov 4:914-27
Strohecker, Anne M; White, Eileen (2014) Targeting mitochondrial metabolism by inhibiting autophagy in BRAF-driven cancers. Cancer Discov 4:766-72
Guo, Jessie Yanxiang; White, Eileen (2013) Autophagy is required for mitochondrial function, lipid metabolism, growth, and fate of KRAS(G12D)-driven lung tumors. Autophagy 9:1636-8
Guo, Jessie Yanxiang; Xia, Bing; White, Eileen (2013) Autophagy-mediated tumor promotion. Cell 155:1216-9
Strohecker, Anne M; Guo, Jessie Yanxiang; Karsli-Uzunbas, Gizem et al. (2013) Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov 3:1272-85

Showing the most recent 10 out of 84 publications